NCT03061292

Brief Summary

Implantation of cardiac implantable electronic devices are generally carried out using intermittent intravenous conscious sedation combined with local anaesthesia. The main advantage of this technique is in avoiding the potential risks of general anaesthesia. However, the use of this Sedation - Local Anaesthesia technique is not without complications. Peri -procedural hypoxaemia and hypotension are well recognised complications of this technique. The pectoral nerves (Pecs) blocks are novel techniques to block the pectoral, intercostobrachial, third to sixth intercostals, and the long thoracic nerves. PECS block targets the lateral and median pectoral nerves at an interfascial plane between the pectoralis major and minor muscles. A case report by Fujiwara et al has described the use of this technique to provide good analgesia during and after these implantation procedures surgery. Pectoral nerves block along with minimal sedation has been used as a safe technique in our local set up as well. Hence, we propose a randomized, single center, controlled trial on patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation with and without Pectoral Nerve Block.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 25, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

4.3 years

First QC Date

February 14, 2017

Last Update Submit

October 6, 2020

Conditions

Outcome Measures

Primary Outcomes (5)

  • Total dose of sedation used

    2 years

  • Incidence of hypoxia, hypotension and hypopnea in the perioperative period

    2 years

  • Perioperative sedation scores

    2 years

  • Perioperative pain scores

    2 years

  • Post-anaesthetic discharge score

    2 years

Secondary Outcomes (2)

  • Procedurist satisfaction scores

    2 years

  • Patient satisfaction scores

    2 years

Study Arms (2)

Pectoral Nerve Block

EXPERIMENTAL

Patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation with pectoral nerve block

Procedure: Pectoral Nerve Block

Without Pectoral Nerve Block

SHAM COMPARATOR

Patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation without pectoral nerve block

Procedure: Without Pectoral Nerve Block

Interventions

Pectoral Nerve Block
Without Pectoral Nerve Block

Eligibility Criteria

Age21 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fulfilled the indication for CIED implantation as defined in 2008 guidelines for device-based therapy of cardiac rhythm abnormalities

You may not qualify if:

  • Pregnant
  • Those who receives subcutaneous implantable cardioverter defibrillator
  • Vulnerable subjects (children, prisoners, cognitive impaired persons)
  • Known history of allergy to local anaesthetic medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changi General Hospital

Singapore, 529889, Singapore

RECRUITING

Central Study Contacts

Vern Hsen Tan, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2017

First Posted

February 23, 2017

Study Start

July 25, 2016

Primary Completion

November 1, 2020

Study Completion

November 1, 2020

Last Updated

October 8, 2020

Record last verified: 2020-10

Locations